CD44 and neoplasm: Since the literature suggests that pituitary ACTH-secreting tumors may contain both EpCAM-positive tumor cells [38] and CD44-positive tumor stromal fibroblast-like cells [39,40], we quantified the populations of EpCAM+ and CD44+ cells via flow cytometry analysis.